Combined ASSNB and ICBPB vs CCBPB in Shoulder Arthroscopy

Last updated: May 14, 2025
Sponsor: Cumhuriyet University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Post-surgical Pain

Chronic Pain

Acute Pain

Treatment

Costoclavicular brachial plexus block (CCBPB)

Infraclavicular Brachial Plexus Block (ICBPB)

Anterior suprascapular nerve block (ASSNB)

Clinical Study ID

NCT06973447
2024-01/08
  • Ages 18-85
  • All Genders

Study Summary

The aim is to compare the postoperative analgesic and hemidiaphragmatic effects of Anterior SupraScapular Nerve Block (ASSNB) and InfraClavicular Brachial Plexus Block (ICBPB) combination versus CostoClavicular Brachial Plexus Block (CCBPB) in patients undergoing shoulder arthroscopic surgery.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adult patients older than 18 years of age who underwent arthroscopic shouldersurgery under general anesthesia and were American Society of Anesthesiologists (ASA) I-II-III according to the ASA risk classification.

Exclusion

Exclusion Criteria:

  • patients who did not give consent,

  • patients with coagulopathy,

  • patients with signs of infection at the block application site,

  • patients using anticoagulants,

  • patients with local anesthetic drug allergies,

  • patients with unstable hemodynamics,

  • patients who could not cooperate during postoperative pain assessment

Study Design

Total Participants: 30
Treatment Group(s): 3
Primary Treatment: Costoclavicular brachial plexus block (CCBPB)
Phase:
Study Start date:
February 20, 2024
Estimated Completion Date:
September 30, 2025

Study Description

Patients were divided into two randomized groups: Group 1 (ASSNB+ICBPB Combination group, n=15) and Group 2 (CCBPB group, n=15). All patients will receive the same standard general anesthesia per hospital protocol. All blocks will be applied with the same ultrasonography and block equipment, and by the same physician. Before the anesthesia induction, ipsilateral diaphragmatic excursion will be measured via Ultrasonography (USG). After the anesthesia induction, patients in Group 1 will receive anterior suprascapular nerve block (ASSNB) with 10 mL of 0.25% bupivacaine and infraclavicular brachial plexus block (ICBPB) with 15 mL of 0.25% bupivacaine (with a total volume of 25 mL). Patients in Group 2 will receive costoclavicular brachial plexus block (CCBPB) with 15 mL of 0.25% bupivacaine. All patients will receive Paracetamol 1gr and Dexketoprofen 50mg intravenous (IV) 10 minutes prior to skin closure. After 30 minutes of emergence from anesthesia (upon reaching 9 points on modified Aldrete scoring), ipsilateral diaphragmatic excursion will be assessed again. Pre- and postblock excursion differences will be recorded. Routine analgesic procedure consisting of 3x1gr Paracetamol and 2x50mg Dexketoprofen will be followed postoperatively for 24 hours. Numeric Rating Scale (NRS) will be used to assess postoperative pain on 1st, 6th, 12th, 18th and 24th hours after the surgery. Quality of Recovery-15 Patient Survey will be done both preoperatively for a baseline score, and postoperatively at 24th hour to assess the quality of recovery from the patients' view. Tramadol 50mg IV will be administered as a rescue analgesic for all patients if NRS score is higher than 4. Total Tramadol consumption will be calculated.

Connect with a study center

  • Sivas Cumhuriyet University

    Sivas, 58140
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.